Literature DB >> 2716220

Mortality rate of schizophrenic patients with tardive dyskinesia during 10 years: a controlled study.

G Yagi, M Takamiya, S Kanba, K Kamijima.   

Abstract

We examined mortality rates (MR) during 10 years between schizophrenic inpatients with and without tardive dyskinesia (TD). The TD group had a significantly higher MR (41%), as compared with the control group (20%). However, we could not reveal critical factors to explain why the TD patients had the higher MR.

Entities:  

Mesh：

Year:  1989        PMID： 2716220     DOI： 10.2302/kjm.38.70

Source DB:  PubMed          Journal:  Keio J Med        ISSN： 0022-9717


  3 in total

1.  A prospective study of tardive dyskinesia in Japan.

Authors:  T Inada; K Ohnishi; M Kamisada; G Matsuda; O Tajima; Y Yanagisawa; K Hashiguchi; S Shima; Y Oh-e; Y Masuda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

2.  Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapyramidal Syndromes Study XIV.

Authors:  Anne E Willems; Charlotte L Mentzel; Pieter Roberto Bakker; Jim Van Os; Diederik E Tenback; Petra Gelan; Erna Daantjes; Glenn E Matroos; Hans W Hoek; Peter N Van Harten
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

3.  Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study.

Authors:  Robert A Hauser; Hadas Barkay; Hubert H Fernandez; Stewart A Factor; Joohi Jimenez-Shahed; Nicholas Gross; Leslie Marinelli; Amanda Wilhelm; Jessica Alexander; Mark Forrest Gordon; Juha-Matti Savola; Karen E Anderson
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.